MENDICINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 144
AS - Asia 110
EU - Europa 70
SA - Sud America 12
OC - Oceania 2
Totale 338
Nazione #
US - Stati Uniti d'America 137
SG - Singapore 59
IT - Italia 38
CN - Cina 19
VN - Vietnam 12
BR - Brasile 10
GB - Regno Unito 10
IN - India 10
DE - Germania 7
FI - Finlandia 4
PL - Polonia 4
HK - Hong Kong 3
BD - Bangladesh 2
CA - Canada 2
CR - Costa Rica 2
MX - Messico 2
NZ - Nuova Zelanda 2
AR - Argentina 1
ES - Italia 1
FR - Francia 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
JP - Giappone 1
LT - Lituania 1
MD - Moldavia 1
NL - Olanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SE - Svezia 1
TR - Turchia 1
UY - Uruguay 1
Totale 338
Città #
San Jose 32
Singapore 27
Ashburn 19
Dallas 12
Santa Clara 9
Chandler 8
Hefei 8
Bengaluru 7
Ho Chi Minh City 6
Chicago 5
London 5
Munich 5
Catanzaro 4
Milan 4
Beijing 3
Boardman 3
Los Angeles 3
Pistoia 3
Auckland 2
Chennai 2
Helsinki 2
Hong Kong 2
Lawrence 2
Princeton 2
Rome 2
Rozzano 2
Turku 2
Warsaw 2
Acri 1
Amsterdam 1
Baependi 1
Baghdad 1
Biên Hòa 1
Bom Despacho 1
Bom Repouso 1
Bowmanville 1
Bragança Paulista 1
Brooklyn 1
Centro Municipality 1
Chacabuco 1
Chisinau 1
Clarksburg 1
Da Nang 1
Denver 1
Des Moines 1
Dhaka 1
Dunfermline 1
Florence 1
Frankfurt am Main 1
Haiphong 1
Hanoi 1
Hanover 1
Kingston 1
Kizlyar 1
Liberia 1
Madrid 1
Maidstone 1
Marseille 1
Mexico City 1
Milwaukee 1
Minneapolis 1
Montreal 1
Phoenix 1
Rangpur City 1
Riyadh 1
Salvador 1
San Francisco 1
San José 1
Santo André 1
Seattle 1
São Gonçalo 1
São Paulo 1
Tibagi 1
Tokyo 1
Turin 1
Vitória de Santo Antão 1
Yalova 1
Totale 232
Nome #
COVID-19: high-JAKing of the inflammatory “flight” by ruxolitinib to avoid the cytokine storm 90
Belantamab mafodotin in multiple myeloma 51
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 50
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 46
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 44
Elotuzumab in multiple myeloma 37
Isatuximab in multiple myeloma 30
Totale 348
Categoria #
all - tutte 2.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 5 0
2021/202215 0 2 0 1 0 7 1 1 0 0 3 0
2022/202326 5 2 1 1 1 2 4 3 3 2 2 0
2023/202441 5 8 4 8 3 9 0 0 0 0 1 3
2024/202570 7 2 1 2 4 10 0 0 12 1 14 17
2025/2026170 14 20 16 11 21 12 32 5 26 13 0 0
Totale 348